Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 151 for “"Dose Escalation"”.

  1. Statistical methods for efficient Phase I dose escalation trials

    Phase I dose escalation studies are first-in-human clinical trials, often with the primary objective of identifying the treatment’s maximum tolerated dose (MTD). This objective is complicated by the intrinsically limited size, scope, and time frame of Phase I clinical trials. In this dissertation …

    umn Repository record for Statistical methods for efficient Phase I dose escalation trials (opens in a new tab)

  2. Positron Emission Tomography for Pre-Clinical Sub-Volume Dose Escalation

    … the use of PET imaging for selective sub-volume dose escalation. Specifically the problems addressed are 1.) The difficulties associated with comparing multiple PET images, 2.) The need for further validation of novel PET tracers before their implementation in dose escalation schema and 3.) The …

    vcu Repository record for Positron Emission Tomography for Pre-Clinical Sub-Volume Dose Escalation (opens in a new tab)

  3. Perfusion SPECT guided dose escalation in radiation therapy for lung cancer patients

    … the sparing of lung is assessed based on the dosevolume histogram (DVH) assuming homogeneous lung function which is clearly not valid. Lung perfusion scan using Single Photon Emission Computed Tomography (SPECT) with ⁹⁹mTc macroaggregated albumin (⁹⁹mTc-MAA) provides unique functional …

    ubc Repository record for Perfusion SPECT guided dose escalation in radiation therapy for lung cancer patients (opens in a new tab) Download PDF for Perfusion SPECT guided dose escalation in radiation therapy for lung cancer patients (opens in a new tab)

  4. Study of dose escalation protocols in prostate cancer radiation therapy with patient realignment by using internal fiducial markers

    … target volume (CTV), which in turn may allow dose escalation. As a first step we do test on 3 patients. Conformal treatment plans for 3 prostate cancer patients were evaluated by using different PTV margins with dose prescription of 70Gy/35fr initially. Two beam arrangements, 4-Field-Box (4FB) …

    ubc Repository record for Study of dose escalation protocols in prostate cancer radiation therapy with patient realignment by using internal fiducial markers (opens in a new tab) Download PDF for Study of dose escalation protocols in prostate cancer radiation therapy with patient realignment by using internal fiducial markers (opens in a new tab)

  5. A Phase I Dose-Escalation Study of The Braf Inhibitor Vemurafenib In Combination With The Mtor Inhibitor Everolimus In Subjects With Advanced Cancer

    … objective is to find the maximum tolerated dose (MTD) and the toxicity of the combination of vemurafenib and everolimus following a standard 3 + 3 design. The most common diagnosis was melanoma in 5 out of 10 patients (50%). Male patients in 7 out of 10 patients (70%). The average age was …

    uthsc Repository record for A Phase I Dose-Escalation Study of The Braf Inhibitor Vemurafenib In Combination With The Mtor Inhibitor Everolimus In Subjects With Advanced Cancer (opens in a new tab)

  6. Medication adherence, persistence, switching and dose escalation with the use of tumor necrosis factor (TNF) inhibitors among Texas Medicaid patients diagnosed with rheumatoid arthritis

    … was to evaluate medication use patterns (i.e., dose escalation, medication adherence, persistence, and switching) of rheumatoid arthritis (RA) patients on etanercept (ETN), infliximab (IFX) or adalimumab (ADA) and the associated healthcare utilization costs using Texas Medicaid data. Study …

    texas Repository record for Medication adherence, persistence, switching and dose escalation with the use of tumor necrosis factor (TNF) inhibitors among Texas Medicaid patients diagnosed with rheumatoid arthritis (opens in a new tab)

  7. Immunological response to R21/Matrix-M and RH5/Matrix-M malaria vaccine in open-label Phase Ib dose escalation and age de-escalation studies in Africa

    … vaccination regimens (vaccine and adjuvant doses, and schedule (0-1-2 vs 0-1-6 months)) of R21/Matrix-M and RH5.1/Matrix-M were assayed for vaccine-specific antibodies by ELISA (quantity); functional assessment (quality) by avidity assay, complement fixation (C1q) assay, inhibition of …

    the-open-u Download PDF for Immunological response to R21/Matrix-M and RH5/Matrix-M malaria vaccine in open-label Phase Ib dose escalation and age de-escalation studies in Africa (opens in a new tab)

  8. Personalized radiation therapy planning for primary prostate cancer: comparative analysis between multiparametric MRI and PSMA PET/CT for focal dose escalation and linking clinical parameters with radiosensitivity

    … for intensifying RT by optimizing radiation doses based on the tumor's unique sensitivity is explored.<br><br>In the clinical study, 93 patients from two German university hospitals underwent pre-therapeutic 3T mpMRI and [18F] PSMA-1007 PET/CT (Freiburg) or [18F] PSMA-1007 PET/MRI (Dresden). …

    freiburg-diss Repository record for Personalized radiation therapy planning for primary prostate cancer: comparative analysis between multiparametric MRI and PSMA PET/CT for focal dose escalation and linking clinical parameters with radiosensitivity (opens in a new tab)

  9. Plan Quality and Isotoxic Dose Escalation Investigation Using a 0.35T MR-Linac System in Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided Radiation Therapy (MRgRT) for Primary Pancreatic Cancer

    … cancer (PCa). In addition, an isotoxic dose escalation was investigated with the MRL TPS based on the stereotactic MR-guided adaptive radiation therapy (SMART) trial constraints. A clinical workflow was developed for adaptive and non-adaptive treatments with the MRL, on which a …

    vcu Repository record for Plan Quality and Isotoxic Dose Escalation Investigation Using a 0.35T MR-Linac System in Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided Radiation Therapy (MRgRT) for Primary Pancreatic Cancer (opens in a new tab)

  10. Προγνωστικοί παράγοντες για μη-ανταπόκριση και απώλεια της ανταπόκρισης σε ασθενείς με φλεγμονώδη νόσο του εντέρου που λαμβάνουν anti-TNF θεραπεία

    … or loss of response and therefore the need for dose escalation and de-escalation in CD and UC patients treated with Infliximab or Adalimumab.Methods: All patients were anti-TNF naïve, while concomitant azathioprine was administered for 6 months. In patients initially responding to anti-TNF and …

    greece Repository record for Προγνωστικοί παράγοντες για μη-ανταπόκριση και απώλεια της ανταπόκρισης σε ασθενείς με φλεγμονώδη νόσο του εντέρου που λαμβάνουν anti-TNF θεραπεία (opens in a new tab)

  11. Novel methods for early phase clinical trials

    … objective. The initial focus of the thesis is on dose-escalation. In the single-agent setting, subgroups of the population, between which the reaction to treatment may differ, are accounted for in dose-escalation. This is achieved using a Bayesian model-based approach to dose-escalation with spike …

    lancaster Download PDF for Novel methods for early phase clinical trials (opens in a new tab)

  12. Bayesian Phase I Dose Finding In Cancer Trials

    This dissertation explores phase I dose-finding designs in cancer trials from three perspectives: the alternative Bayesian dose-escalation rules, a design based on a time-to-dose-limiting toxicity (DLT) model, and a design based on a discrete-time multi-state (DTMS) model. We list alternative …

    uthsc Repository record for Bayesian Phase I Dose Finding In Cancer Trials (opens in a new tab)

  13. Catheter Placement Optimization using Hybrid Inverse Planning and Optimization for Focal High Dose Rate Brachytherapy in Patients with Pubic Arch Interference

    … outcomes are well correlated with an increase in dose delivered to the Dominant Intraprostatic Lesion (DIL) in prostate cancer radiotherapy treatments. The DIL represents a concentration of high-grade cancerous tissue and is the most common site of prostate cancer recurrence. One of the most …

    calgary Repository record for Catheter Placement Optimization using Hybrid Inverse Planning and Optimization for Focal High Dose Rate Brachytherapy in Patients with Pubic Arch Interference (opens in a new tab)

  14. Intensity modulated radiotherapy for skull base meningioma

    … is an effective treatment for meningioma, with doses of 50-54Gy in conventional fractionation schedules resulting in long-term local control rates of 80-90%. However, local recurrence is unacceptably high in aggressive histological subtypes (WHO G2 and G3), and these patients have a poor outcome …

    auckland-ms Repository record for Intensity modulated radiotherapy for skull base meningioma (opens in a new tab)

  15. The role of advanced imaging techniques in radiotherapy for head and neck cancer

    … diagnostic modality, in guiding radiotherapy dose escalation. It is based on the results of the FiGaRO study (<sup>18</sup>F-FDG-PET in Guiding Dose-Painting with Intensity Modulated Radiotherapy in Oropharyngeal Tumours). This was a multi-centre phase I Feasibility Study aiming to test the …

    kings Repository record for The role of advanced imaging techniques in radiotherapy for head and neck cancer (opens in a new tab)

  16. Widening the therapeutic window of thoracic radiotherapy: cardiopulmonary toxicity modelling

    … remain poor despite attempts with radiation dose escalation to improve overall survival (OS). A major limitation of radiation dose escalation is normal tissue toxicity. Here, I investigate the hypothesis that cardiac and its substructure irradiation impact OS in LA-NSCLC patients with a …

    oxford Repository record for Widening the therapeutic window of thoracic radiotherapy: cardiopulmonary toxicity modelling (opens in a new tab)

  17. Evaluation of proton treatment strategies for head and neck cancer and lung cancer based on treatment planning studies

    … cancer patients using a biologically adapted dose escalation schedule with photon and proton therapy. The feasibility of the dose escalation schedule could be demonstrated for both photon and proton therapy, since only a small increase in toxicity risk occurred for most toxicities. However, …

    qucosa-diss

Page 1 of 8